Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-09-24

Clinical Trial Update: IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients [NA]

View source ↗

Summary

The trial update indicates that intraocular pressure reduction was observed after anecortave acetate injections in glaucoma patients. The current status of the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anecortave acetate (anecortave acetate)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Glaucoma, Intraocular Pressure | NA | Status: UNKNOWN